News Focus
News Focus
Followers 60
Posts 427
Boards Moderated 0
Alias Born 03/24/2014

Re: CTMedic post# 161028

Friday, 04/23/2021 8:09:40 AM

Friday, April 23, 2021 8:09:40 AM

Post# of 236661
100% FDA - 100% correct!

And to change the dosage mid-trial there has to be a strong signal that the design dosage is not working at all, which was not the case as we learned.

Much further down the trial timeline, and with a larger patient population which also included a more diverse set of health conditions and outcomes, the evidence became clearer regarding the difference dose 3 & 4 make.

- FDA disallowed it at first
- It severely impacted trial outcomes (and more importantly patient lives)
- FDA washes hands and no one can be held accountable (or will come forward and BE accountable)

We move on to other designs while whistling a tune as if nothing happened.

MH
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News